US Patent Issued to Jubilant Draximage on Feb. 3 for "Radiopharmaceutical conjugate compound for diagnosis and/or therapeutic uses thereof" (Canadian, American Inventors)

ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,539,339, issued on Feb. 3, was assigned to Jubilant Draximage Inc. (India).

"Radiopharmaceutical conjugate compound for diagnosis and/or therapeutic uses thereof" was invented by Indranil Nandi (Yardley, Pa.), Vijayaraj Kuniyil Kulangara (Montreal), Miriam Ruiz Pena (Kirkland, Canada), Aida Mary Abreu Diaz (Kirkland, Canada) and Sara Elkashef (Kirkland, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a conjugate compound comprising a nanoparticulated enhanced permeability and retention (EPR) agent, which is an albumin, conjugated with one or more chelating agents, one or more target specific ligands and one or more de...